Stay updated with breaking news from Stephenw Stripling. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Berdazimer topical gel, 10.3% (Zelsuvmi; Ligand Pharmaceuticals Inc) has been approved for the treatment of molluscum contagiosum in individuals aged 1 year and older.
Berdazimer gel led to 30% complete/near-complete clearance after 12 weeks in randomized trials
The FDA decision on berdazimer gel, 10.3%, represents the second approved treatment for the viral-borne skin disease.
ZELSUVMI™ is expected to be commercially available during the second half of 2024 ...